539138
Protease Inhibitor Cocktail VII
liquid, for the inhibition of serine proteases, cysteine proteases, aspartic proteases and thermolysin-like proteases and aminopeptidases. Recommended for purification of proteins containing His•Tag sequences.
別名:
Protease inhibitor
ログイン組織・契約価格を表示する
すべての画像(1)
About This Item
おすすめの製品
製品名
Protease Inhibitor Cocktail Set VII, Protease Inhibitor Cocktail Set VII contains five protease inhibitors with broad specificity. Recommended for purification of proteins containing His•Tag sequences.
フォーム
liquid
メーカー/製品名
Calbiochem®
保管条件
OK to freeze
輸送温度
wet ice
保管温度
−20°C
関連するカテゴリー
詳細
A cocktail of five protease inhibitors with broad specificity for the inhibition of cysteine, serine, aspartic, and thermolysin-like proteases and aminopeptidases. This cocktail is recommended for purification of proteins containing His•Tag sequences. Each vial contains 100 mM AEBSF, HCl (Cat. No. 101500), 5 mM Bestatin (Cat. No. 200484), 1.5 mM E-64 (Cat. No. 324890), 2 mM Pepstatin A (Cat. No. 516481), and 200 µM of Phosphoramidon, Disodium Salt (Cat. No. 525276). One ml is recommended for the inhibition of proteases in 10 g of cells. Supplied with a data sheet. Note: 1 set = 5 x 1 ml.
This set is a specially formulated protease inhibitor cocktail of five protease inhibitors with broad specificity for the inhibition of cysteine, serine, aspartic, and thermolysin-like proteases and aminopeptidases. This cocktail is recommended for purification of histidine-tagged proteins.
This product is provided as a single vial or as a set of 5 vials. Each vial contains 1 ml of protease inhibitor cocktail solubilized in DMSO with the following components:
This product is provided as a single vial or as a set of 5 vials. Each vial contains 1 ml of protease inhibitor cocktail solubilized in DMSO with the following components:
特異性
Inhibits serine proteases, cysteine proteases, aspartic proteases and thermolysin-like proteases and aminopeptidases.
警告
Toxicity: Irritant (B)
物理的形状
In 1 ml DMSO.
法的情報
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
シグナルワード
Warning
危険有害性情報
危険有害性の分類
Eye Irrit. 2 - Skin Irrit. 2
保管分類コード
10 - Combustible liquids
WGK
WGK 2
引火点(°F)
188.6 °F
引火点(℃)
87 °C
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
消防法
第4類:引火性液体
第三石油類
危険等級III
非水溶性液体
Jan Code
539138-1SET:
539138-1SML:
539138-1ML:
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
この製品を見ている人はこちらもチェック
Methods in molecular biology (Clifton, N.J.), 2473, 101-128 (2022-07-13)
The entanglement of long axons found in cultured dissociated hippocampal neurons restricts the analysis of the machinery underlying directed axonal trafficking. Further, hippocampal neurons exhibit "en passant" presynapses that may confound the analysis of long-range retrograde axonal transport. To solve
The Journal of biological chemistry, 299(7), 104834-104834 (2023-05-19)
Chromatin organization is highly dynamic and modulates DNA replication, transcription, and chromosome segregation. Condensin is essential for chromosome assembly during mitosis and meiosis, as well as maintenance of chromosome structure during interphase. While it is well established that sustained condensin
Molecules (Basel, Switzerland), 23(5) (2018-05-23)
We demonstrate for the first time that 4H-1,2,6-thiadiazin-4-one (TDZ) can function as a chemotype for the design of ATP-competitive kinase inhibitors. Using insights from a co-crystal structure of a 3,5-bis(arylamino)-4H-1,2,6-thiadiazin-4-one bound to calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2), several analogues
Cancer research, 83(7), 997-1015 (2023-01-26)
Breast cancer subtypes and their phenotypes parallel different stages of the mammary epithelial cell developmental hierarchy. Discovering mechanisms that control lineage identity could provide novel avenues for mitigating disease progression. Here we report that the transcriptional corepressor TLE3 is a
Cell reports. Medicine, 5(6), 101580-101580 (2024-05-23)
Natural killer (NK) cell-based immunotherapy holds promise for cancer treatment; however, its efficacy remains limited, necessitating the development of alternative strategies. Here, we report that venetoclax, an FDA-approved BCL-2 inhibitor, directly activates NK cells, enhancing their cytotoxicity against acute myeloid
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)